Genetic and Functional Characterization of Congenital HCMV Clinical Strains in Ex Vivo First Trimester Placental Model.

clinical strains congenital cytomegalovirus mutations placenta viral kinetics

Journal

Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317

Informations de publication

Date de publication:
27 Jul 2023
Historique:
received: 15 04 2023
revised: 19 07 2023
accepted: 20 07 2023
medline: 25 8 2023
pubmed: 25 8 2023
entrez: 25 8 2023
Statut: epublish

Résumé

Human cytomegalovirus (HCMV) is the leading cause of congenital viral infection, leading to a variety of symptoms in the unborn child that range from asymptomatic to death in utero. Our objective was to better understand the mechanisms of placental infection by HCMV clinical strains, particularly during the first trimester of pregnancy. We thus characterized and compared the replication kinetics of various HCMV clinical strains and laboratory strains by measuring viral loads in an ex vivo model of first trimester villi and decidua, and used NGS and PCA analysis to analyze the genes involved in cell tropism and virulence factors. We observed that first trimester villi and decidua are similarly permissive to laboratory and symptomatic strains, and that asymptomatic strains poorly replicate in decidua tissue. PCA analysis allowed us to segregate our clinical strains based on their clinical characteristics, suggesting a link between gene mutations and symptoms. All these results bring forth elements that can help better understand the mechanisms that induce the appearance of symptoms or in the congenitally infected newborn.

Identifiants

pubmed: 37623946
pii: pathogens12080985
doi: 10.3390/pathogens12080985
pmc: PMC10460061
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Sanofi Pasteur, and Santé Publique France
ID : contrat de collaboration 2021

Références

PLoS One. 2022 Jan 26;17(1):e0262953
pubmed: 35081137
Sci Rep. 2019 Nov 8;9(1):16352
pubmed: 31705022
Placenta. 2017 Nov;59 Suppl 1:S8-S16
pubmed: 28477968
PLoS One. 2012;7(12):e52899
pubmed: 23300810
J Mol Biol. 1967 Jun 14;26(2):365-9
pubmed: 4291934
Pediatr Infect Dis J. 2017 Dec;36(12):1205-1213
pubmed: 29140947
Clin Infect Dis. 2010 Jul 1;51(1):33-41
pubmed: 20504230
J Virol. 2005 Aug;79(16):10330-8
pubmed: 16051825
J Gen Virol. 2010 Jun;91(Pt 6):1535-46
pubmed: 20479471
Antiviral Res. 2020 Mar;175:104700
pubmed: 31870762
Pediatr Infect Dis J. 2013 Oct;32(10):1050-4
pubmed: 23694837
Infect Dis Clin North Am. 2015 Sep;29(3):401-14
pubmed: 26154664
J Virol. 2000 Aug;74(15):6808-20
pubmed: 10888620
Placenta. 2011 Jul;32(7):522-30
pubmed: 21605903
J Reprod Immunol. 2014 Mar;101-102:74-79
pubmed: 23747129
J Infect Dis. 2004 Aug 15;190(4):826-34
pubmed: 15272412
Virol J. 2021 Jun 3;18(1):112
pubmed: 34082757
Semin Immunopathol. 2014 Nov;36(6):615-25
pubmed: 25291972
Rev Med Virol. 2007 Jul-Aug;17(4):253-76
pubmed: 17579921

Auteurs

Deborah Andouard (D)

Bacteriology-Virology-Hygien Department, National Reference Center for Herpesviruses, Centre Hospitalier Universitaire de Limoges, 87000 Limoges, France.
RESINFIT-Antimicrobials: Molecular Supports of Resistances and Therapeutic Innovations, UMR Inserm 1092, University of Limoges, 87000 Limoges, France.
Sanofi Vaccines R&D, 69280 Marcy-l'étoile, France.

Valentin Tilloy (V)

Bacteriology-Virology-Hygien Department, National Reference Center for Herpesviruses, Centre Hospitalier Universitaire de Limoges, 87000 Limoges, France.
UF9481 Bioinformatics Department, CHU Dupuytren, 87000 Limoges, France.

Elodie Ribot (E)

Bacteriology-Virology-Hygien Department, National Reference Center for Herpesviruses, Centre Hospitalier Universitaire de Limoges, 87000 Limoges, France.

Melissa Mayeras (M)

Bacteriology-Virology-Hygien Department, National Reference Center for Herpesviruses, Centre Hospitalier Universitaire de Limoges, 87000 Limoges, France.

Daniel Diaz-Gonzalez (D)

RESINFIT-Antimicrobials: Molecular Supports of Resistances and Therapeutic Innovations, UMR Inserm 1092, University of Limoges, 87000 Limoges, France.
UF8843 Medical Genomics Department, CHU Dupuytren, 87000 Limoges, France.

Chahrazed El Hamel (C)

Pediatric Department, Mother and Child Biobank (CB-HME), Hôpital de la Mère et de l'enfant, CHU Limoges, 87000 Limoges, France.

Fabienne Piras-Douce (F)

Sanofi Vaccines R&D, 69280 Marcy-l'étoile, France.

Nathalie Mantel (N)

Sanofi Vaccines R&D, 69280 Marcy-l'étoile, France.

Sophie Alain (S)

Bacteriology-Virology-Hygien Department, National Reference Center for Herpesviruses, Centre Hospitalier Universitaire de Limoges, 87000 Limoges, France.
RESINFIT-Antimicrobials: Molecular Supports of Resistances and Therapeutic Innovations, UMR Inserm 1092, University of Limoges, 87000 Limoges, France.
UF8843 Medical Genomics Department, CHU Dupuytren, 87000 Limoges, France.

Classifications MeSH